Our results provided clear in vivo experimental support that a bioactive dipeptide combined with exercise protects the myocardium from hypertension by alleviating fibrosis, hypertrophy, and inflammation through AMPKα1/SIRT1/PGC1α. The gene discussed is PPARGC1A; the disease is hypertensive disorder.